Thoracoabdominal Aortic Aneurysms

Outcomes of Endovascular Repair of Thoracoabdominal Aortic Aneurysms

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06267573

Enrollment

100

Registered

2024-02-20

Start date

2024-09-30

Completion date

2026-09-10

Last updated

2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoabdominal Aortic Aneurysm

Brief summary

Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA

Interventions

DEVICEFenestrated and branched endovascular devices for TAAA

Devices for TAAA

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* all adult consecutive patients presenting with TAAA larger than 5.5 cm

Exclusion criteria

* active infection Asymptomatic patients with small aneurysms Allergy to contrast agents

Design outcomes

Primary

Measure	Time frame	Description
Successful cannulation of the target vessels with complete in-line flow to target organs.	Two years	No ischemia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026